INVESTABOT
Equity Research
XNAS · WHOLESALE-MISCELLANEOUS NONDURABLE GOODS · WHOLESALE-MISCELLANEOUS NONDURABLE GOODS
Includes notes from domestic 8-K and foreign private issuer 6-K disclosures.
TL;DR: Natural Health Trends posted Q1 2026 revenue of $9.2M, down 14% from $10.7M a year ago, while EPS swung to a loss of $0.02 from a gain of $0.01 per diluted share in Q1 2025.
| Institution | Shares | Value ($) | Change % | Filing date |
|---|---|---|---|---|
| Renaissance Technologies | 581,415 | $1,796,572 | — | 2/12/2026 |
| Renaissance Technologies | 555,415 | $1,549,608 | -4.5% | 5/14/2026 |
| Renaissance Technologies | 544,077 | $963,016 | -2.0% | 8/13/2026 |
| BlackRock | 115,591 | $820,696 | — | 8/13/2024 |
| BlackRock | 115,339 | $356,398 | — | 2/12/2026 |
| Vanguard Group | 113,739 | $351,453 | — | 1/29/2026 |
| BlackRock | 116,134 | $324,014 | 0.7% | 5/13/2026 |
| Citadel Advisors | 60,871 | $188,091 | — | 2/17/2026 |
| BlackRock | 95,588 | $169,191 | -17.7% | 8/7/2026 |
| Citadel Advisors | 44,014 | $122,799 | -27.7% | 5/15/2026 |
| State Street | 27,012 | $83,467 | — | 2/13/2026 |
| State Street | 27,012 | $75,363 | 0.0% | 5/15/2026 |
| Citadel Advisors | 37,888 | $67,062 | -13.9% | 8/14/2026 |
| State Street | 27,012 | $47,811 | 0.0% | 8/7/2026 |
| Fidelity (FMR) | 158 | $441 | 100.0% | 5/15/2026 |
| Morgan Stanley | 17 | $53 | — | 5/27/2026 |
| Morgan Stanley | 18 | $50 | 5.9% | 5/15/2026 |
| Morgan Stanley | 26 | $46 | 44.4% | 8/13/2026 |
| Fidelity (FMR) | 0 | $0 | -100.0% | 8/13/2026 |